Skip to content

Efficacy of photodynamic therapy (PDT) of 5-Aminolevulinic Acid for cervical intraepithelial neoplasia

Efficacy of photodynamic therapy (PDT) of 5-Aminolevulinic Acid for cervical intraepithelial neoplasia - ALA-PDT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010412
Enrollment
120
Registered
2013-04-03
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical intraepithelial neoplasia(CIN)

Interventions

CIN3 CIN1/2

Sponsors

Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Pathological diagnosis within 3 months by Central Pathological Review 2) 2groups I)CIN3 II)CIN1/2 3) 20-50years-old 4) ECOG Performance Status (PS)0-2 5) Patients with organ function is maintained sufficiently 6) Patients consent of patients was obtained in writing 7) A outpatient

Exclusion criteria

Exclusion criteria: 1) Patients (including tuberculosis activities) uncontrolled infection. 2) Patients with severe underlying disease (Malignant hypertension. With severe congestive heart failure. Severe liver failure. Myocardial infarction within 3 months. End-stagecirrhosis. Poorly controlled diabetes. Severe pulmonary fibrosis. Interstitial pneumonia activity) 3) Allogeneic bone marrow transplantation 4) Patients with severe mental disorders 5) Patients with porphyria or hypersensitivity to porphyrins allergy 6) A gravida, a lactational woman 7) Patients with severe anemiallegy 8) Patients were deemed inappropriate by research investigators 9) Patients with CIN1 within 2years

Design outcomes

Primary

MeasureTime frame
efficacy (rate of complete response)

Secondary

MeasureTime frame
Safety

Countries

Japan

Contacts

Public ContactMika Mizuno

Aichi cancer center Department of Gynecology

mizunomizuno@med.nagoya-u.ac.jp052-744-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026